Is a complete LON/0QAH research report available?

No complete published report is available for lon/0QAH (LON/0QAH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/0QAH stock profile: metrics, valuation and analysis

Market cap	263.9B
Revenue (ttm)	50.2B
Net income (ttm)	2.4B
EPS (ttm)	$0.96
P/E (trailing)	110.4x
P/E (forward)	16.5x
Dividend	$2.56 (2.39%)
Volume	9,547
Beta	0.21

All LON/0QAH indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	75,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$298.5B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US58933Y1055
Last refreshed	2026-09-11
Market cap	$263.9B
Price	$145
Price currency	USD
Rev Per Employee	678,014.26x
Sector	Healthcare
Sector PE	20.62
Sector PE Fwd	13.37
Sic	2834
Symbol	lon/0QAH
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.91%
EV Earnings	124.83x
EV/EBIT	17.2x
EV/EBITDA	13.79x
EV/FCF	24.66x
EV/Sales	6.07x
FCF yield	4.59%
Forward P/E	16.46x
P/B ratio	8.34x
P/E ratio	110.36x
P/S ratio	5.26x
PE Ratio10 Y	56.04x
PE Ratio3 Y	100.29x
PE Ratio5 Y	71.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	35.28%
EBITDA Margin	43.37%
FCF margin	24.57%
Gross margin	75.9%
Gross Profit	$38.1B
Gross Profit Growth	2.6%
Gross Profit Growth Q	0.52%
Gross Profit Growth3 Y	5.77%
Gross Profit Growth5 Y	9.69%
Net Income	$2.4B
Net Income Growth	-80.66%
Net Income Growth Years	2%
Net Income Growth3 Y	0.66%
Net Income Growth5 Y	-10.64%
Pretax Margin	8.94%
Profit Margin	4.77%
Profit Per Employee	$32,317
Profitable Years	14
ROA	11.87
Roa5y	11.18
ROCE	23.01
ROE	6.96
Roe5y	30.37
ROIC	14.05
Roic5y	22.36

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.1%
Cagr15y	14.26%
Cagr1y	77.08%
Cagr3y	13.75%
Cagr5y	17.46%
Div CAGR10	6.33%
Div CAGR3	5.2%
Div CAGR5	5.51%
EPS Growth	-80.37
EPS Growth Years	2
EPS Growth3 Y	1.25
EPS Growth5 Y	-10.38
FCF Growth	9.11%
FCF Growth Q	77.03%
FCF Growth Qo Q	52.96%
FCF Growth3 Y	14.05%
FCF Growth5 Y	18.23%
OCF Growth	7.73%
OCF Growth Q	63.07%
OCF Growth Qo Q	37.06%
OCF Growth10 Y	5.83%
OCF Growth3 Y	9.82%
OCF Growth5 Y	10.91%
Revenue Growth	4.64x
Revenue Growth Q	5.07x
Revenue Growth Qo Q	1.97x
Revenue Growth Quarters	4x
Revenue Growth Years	6x
Revenue Growth3 Y	4.51x
Revenue Growth5 Y	8.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.54
Assets	$97.8B
Cash	$5.4B
Current Assets	$27.1B
Current Liabilities	$20.5B
Debt	$40.6B
Debt EBITDA	$1.84
Debt Equity	$1.28
Debt FCF	$3.36
Equity	$31.6B
Interest Coverage	13.47
Liabilities	$66.2B
Long Term Assets	$70.7B
Long Term Liabilities	$45.7B
Net Cash	$-35.3B
Net Cash By Market Cap	$-13.36
Net Debt EBITDA	$1.62
Net Debt Equity	$1.11
Net Debt FCF	$2.91
Tangible Book Value	$-3.5B
Tangible Book Value Per Share	$-1.41
WACC	4.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.32
Inventory Turnover	2.51
Net Working Capital	$3.5B
Quick ratio	0.74
Working Capital	$6.7B
Working Capital Turnover	$5.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.92%
Dividend Growth	4.94%
Dividend Growth Years	16%
Dividend per share	$2.56
Dividend Years	23
Dividend Yield	2.39%
Ex Div Date	2026-09-15
Last Dividend	$0.85
Payout Frequency	Quarterly
Payout Ratio	261.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	213.37%
1Y total return	77.01%
200-day SMA	119.3
3Y total return	47.18%
50-day SMA	136.2
50-day SMA vs 200-day SMA	50over200
5Y total return	123.52%
All Time High	157.9
All Time High Change	-8.42%
All Time High Date	2026-08-26
All Time Low	21.96
All Time Low Change	558.56%
All Time Low Date	2009-04-29
ATR	4.92
Beta	0.21
Ch YTD	36.88
High	149.7
High52	157.9
High52 Date	2026-08-26
High52ch	-8.42%
Low	144.2
Low52	70.15
Low52 Date	2025-10-02
Low52ch	106.17%
Ma50ch	6.19%
Price vs 200-day SMA	21.24%
RSI	51.41
RSI Monthly	69.51
RSI Weekly	65.16
Sharpe ratio	1.93x
Sharpe Ratio3y	0.47x
Sharpe Ratio5y	0.64x
Sortino ratio	3.82
Sortino Ratio3y	0.95
Sortino Ratio5y	1.2
Total Return	4.31%
Tr YTD	38.87
Tr15y	638.67%
Tr1m	12.69%
Tr1w	-4.23%
Tr3m	21.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,463,032,888%
Net Borrowing	13,832,446,464
Shares Insiders	0.05%
Shares Institutions	81.48%
Shares Qo Q	-0.08%
Shares Yo Y	-1.92%
Short Ratio	2.33

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$11.4B
Adjusted OCF	14,376,827,500
Average Volume	27,885.6x
Bv Per Share	12.8
CAPEX	$-2.9B
Ch10y	130.7
Ch15y	339.9
Ch1m	12.69
Ch1w	-4.23
Ch1y	71.31
Ch3m	20.43
Ch3y	34.28
Ch5y	91.55
Ch6m	24.58
Change	-2.36%
Change From Open	-2.66
Close	148.1
Days Gap	0.3
Depreciation Amortization	3,988,079,064
Dollar Volume	1,380,687.1
Earnings Date	2026-10-29
EBIT	$17.7B
EBITDA	$21.8B
EPS	$0.96
F Score	4
FCF	$12.1B
FCF EV Yield	4.06x
Financing CF	4,650,329,000
Fiscal Year End	December
Founded	1,891
Goodwill	15,974,521,596
Graham Number	22.6115
Graham Upside	-84.36
Income Tax	$2.1B
Investing CF	-20,572,995,200
Is Primary Listing	0
Last Earnings Date	2026-08-04
Last Report Date	2026-06-30
Lynch Fair Value	$6.55
Lynch Upside	-95.47
Ma150	123.9
Ma150ch	16.69%
Ma20	148.2
Ma20ch	-2.39%
Net CF	-890,873,400
Next Earnings Date	2026-10-29
Open	148.6
P FCF Ratio	21.8
P FCF Ratio SBC	23.08
P OCF Ratio	17.54
P OCF Ratio SBC	18.36
Payment Date	2026-10-07
Position In Range	8.26
Ppne	19,049,961,186
Price Date	2026-09-10
Price EBITDA	$12.13
Relative Volume	0.34x
Revenue	50,173,055,300x
SBC By Revenue	1.34x
Share Based Comp	672,300,400
Tax By Revenue	4.17x
Tax Rate	46.72%
Tr6m	26.39%
Volume	9,547
Z Score	3.6

LON/0QAH (LON/0QAH)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0QAH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0QAH indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0QAH

Frequently asked questions